AMGN

Amgen Inc. News Headlines

$162.24
*  
1.94
1.18%
Get AMGN Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Amgen,AstraZeneca Report Positive Results From Phase 3 Study Of Brodalumab
11/25/2014 10:06:00 PM - RTT News


Last Phase 3 brodalumab psoriasis trial successful
11/25/2014 4:47:00 PM - Seeking Alpha


Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog
11/25/2014 1:20:00 PM - Zacks.com


I'm Letting Amgen Cool Down Before Buying Any More Shares Right Now
11/25/2014 11:17:00 AM - Seeking Alpha


Today's Market: Record Highs Continue, Stocks In The News
11/25/2014 10:25:00 AM - Seeking Alpha


Drug makers face pushback on pricey meds
11/25/2014 8:18:00 AM - Seeking Alpha


Novartis' Psoriasis Drug Cosentyx Backed for EU Approval - Analyst Blog
11/24/2014 6:40:00 PM - Zacks.com


Holiday Fever Takes Hold Of Stock Investors, But A Pullback Is Needed
11/24/2014 4:14:00 PM - Seeking Alpha


JANA Partners opens a stake in Amgen
11/24/2014 12:00:00 PM - Market Realist


Amgen Terminates Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
11/24/2014 9:25:00 AM - RTT News


JANA Partners adds a large stake in Dollar General
11/24/2014 8:00:00 AM - Market Realist


Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year
11/24/2014 7:53:03 AM - Motley Fool


Week In Review: Cross-Border Deals Dominate The Week's News
11/24/2014 3:46:00 AM - Seeking Alpha


Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update
11/24/2014 2:26:00 AM - Seeking Alpha


DealBook: When activist investors aim at strong companies, America loses
11/22/2014 8:25:00 AM - Seeking Alpha


Highlights of activist fund JANA Partners’ 3Q 13F
11/21/2014 8:30:00 PM - Market Realist


Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog
11/21/2014 5:00:00 PM - Zacks.com


Amgen Claims It All
11/21/2014 12:58:00 PM - Seeking Alpha


Regeneron & Sanofi Present Positive Data on PCSK9 Drug - Analyst Blog
11/20/2014 4:30:00 PM - Zacks.com


Positive clinical trial results for alirocumab presented at AHA meeting
11/19/2014 12:35:00 PM - Seeking Alpha


Amgen To Present At Jefferies Global Healthcare Conference;Webcast At 3:40 AM ET
11/19/2014 2:40:00 AM - RTT News


Gilead's Value Without Its Hep C Franchise
11/18/2014 4:07:00 PM - Seeking Alpha


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


Notable ETF Outflow Detected - IWF, SLB, AMZN, AMGN
11/17/2014 11:31:37 AM - BNK Invest


Biotech: And Yet We've Just Begun...
11/14/2014 10:06:21 AM - Martin Tillier